As of Nov 27
| +0.0021 / +0.39%|
The 5 analysts offering 12-month price forecasts for StemCells Inc have a median target of 2.00, with a high estimate of 5.00 and a low estimate of 1.55. The median estimate represents a +270.37% increase from the last price of 0.54.
The current consensus among 5 polled investment analysts is to Buy stock in StemCells Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.